How to Save Money on COVID-19 Antiviral Treatment in 2026: Coupons, Discounts, and Patient Assistance

Paxlovid's retail price — between $1,390 and $1,820 for a five-day course — can be shocking, especially when you're sick and not expecting a major bill. But the good news is that the vast majority of patients can get COVID-19 antiviral treatment for little to no cost in 2026, if they know which programs to use.

Here's a comprehensive guide to savings options for Paxlovid and other SARS-CoV-2 antivirals.

Option 1: Pfizer's PAXCESS Program — Free for Many Patients

Pfizer's PAXCESS Patient Support Program is the most important savings resource for Paxlovid in 2026. It has two components:

• PAXCESS Co-Pay Card (commercially insured patients): Eligible patients with private or commercial insurance can use the PAXCESS co-pay savings card to pay as little as $0 per prescription, with maximum annual savings of $1,500. Find this card at paxlovid.com.
• U.S. Government Patient Assistance Program (USG PAP) — uninsured and Medicare/Medicaid: Eligible uninsured and underinsured patients, as well as qualifying Medicare and Medicaid patients, can receive Paxlovid at no cost through December 31, 2026. Income eligibility criteria apply. Enrollment takes approximately 5 minutes at paxlovid.iassist.com or by calling 1-877-219-7225.

Option 2: Insurance Coverage — What to Expect

Most insurance plans cover Paxlovid in 2026, but your out-of-pocket cost varies:

• Commercial insurance: Copay ranges from $0 (with PAXCESS co-pay card) to $75+ depending on your plan tier. Coinsurance-based plans may charge 10–30% of the negotiated price before assistance.
• Medicare Part D: Required to cover oral COVID-19 antivirals. The 2026 annual out-of-pocket cap is $2,100. Eligible Medicare patients may also qualify for the PAXCESS USG PAP for no-cost access.
• Medicaid: Covered; check your specific plan for cost-sharing details. Qualifying Medicaid patients may also use the PAXCESS USG PAP.
• ACA Marketplace plans: More likely than other plan types to require prior authorization for Paxlovid. Act quickly — file PA with your provider's office while you're picking up the prescription.

Option 3: GoodRx and Pharmacy Discount Cards

Pharmacy discount cards like GoodRx and SingleCare typically offer modest discounts on brand-name medications like Paxlovid. Since Paxlovid has no generic and the brand has its own assistance program, these cards generally offer less dramatic savings than they do for generic medications. However, they may be useful if you don't qualify for PAXCESS or need to fill quickly while waiting for assistance enrollment.

Important: You generally cannot combine GoodRx discounts with insurance. Use whichever gives you the lower price, but check the PAXCESS program first — it's usually the better option.

Option 4: Savings on Remdesivir (Veklury)

Remdesivir, Gilead's IV antiviral, costs approximately $2,000–$3,000 for a three-day outpatient course. However, since it's administered intravenously at a medical facility, Medicare Part B (not Part D) covers it, which can mean lower out-of-pocket costs for Medicare patients. Gilead's Advancing Access program provides financial assistance for eligible patients; call 1-800-226-2056 or visit veklury.com/patient-support.

Option 5: Savings on Molnupiravir (Lagevrio)

If commercially available, Lagevrio (molnupiravir) costs approximately $700–$1,000 for a five-day course. Merck's MerckHelps patient assistance program provides Lagevrio at no cost to eligible uninsured patients. Visit merckhelps.com or call 1-800-727-5400. Enrollment takes 10–20 minutes to determine eligibility.

What About Prior Authorization — Will It Delay My Treatment?

Prior authorization is increasingly required for Paxlovid in 2026, particularly for ACA marketplace plans. The turnaround can be same-day or up to 2–3 days. Given the 5-day treatment window, this is a real clinical concern. To minimize delays:

• Ask your prescriber to file the PA request immediately, not after you've tried to fill the prescription
• Request a peer-to-peer review if initial PA is denied
• If PA will take more than 1–2 days, ask about paying cash with PAXCESS assistance as a bridge

Quick Reference: Savings Programs for COVID-19 Antivirals

• Paxlovid — PAXCESS Co-Pay Card: $0 for commercially insured | paxlovid.com
• Paxlovid — USG PAP: Free for eligible uninsured/Medicare/Medicaid (through Dec 2026) | 1-877-219-7225
• Remdesivir — Gilead Advancing Access: Financial assistance for eligible patients | 1-800-226-2056
• Molnupiravir — MerckHelps: Free for eligible uninsured patients | merckhelps.com or 1-800-727-5400

Don't Let Cost Stop You From Getting Treated

COVID-19 antiviral treatment is one of the most cost-assisted medications in 2026. The retail sticker price of $1,400+ is scary, but between Pfizer's PAXCESS program, insurance coverage, and Medicare Part D caps, most patients pay little to nothing. The bigger obstacle is often finding the medication in stock. medfinder can help you locate a pharmacy with availability near you.